1. Zhou J, Chen Q. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway. FASEB J. 2019;33:3420–36.
2. Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 1981;5:241–8.
3. Ohgaki M, Toshio T, Akeo H, Yamasaki J, Togawa T. Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepatogastroenterology. 1999;46:2096–9.
4. Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Hagiwara A, Yamagishi H. Tumor recurrence and its timing following curative resection of early gastric carcinoma. Anticancer Res. 2003;23:3499–503.
5. Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased sur- vival time. Cancer. 1992;70:392–5.
6. Japanese gastric cancer treatment guidelines 2018. (5th ed.). Gastric Cancer. 2020.
7. Sobin LH, Gospodarowicz MK, Wittekind C. International Union against cancer. TNM classification of malignant tumours Chichester West Sussex. Wiley-Blackwell; 2010.
8. Zhou Y, Zhang GJ, Wang J, Zheng KY, Fu W. Current status of lymph node micrometastasis in gastric cancer. Oncotarget. 2017;8:51963–9.
9. Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS-Y. Prognos- tic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer. 2002;94:2867–73.
10. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9:771–4.
11. Eguchi T, Kodera Y, Nakanishi H, Yokoyama H, Ohashi N, Ito Y, et al. The effect of chemotherapy against micrometastases and isolated tumor cells in lymph nodes: an in vivo study. Vivo. 2008;22:707–12.
12. Williams JR. The ethics activities of the World Medical Asso- ciation. Sci Eng Ethics. 2005;11:7–12.
13. Japanese classification of gastric carcinoma (3rd English ed.). Gastric Cancer. 2011;14:101–12.
14. Fujiwara Y, Okada K, Hanada H, Tamura S, Kimura Y, Fujita J, et al. The clinical importance of a transcription reverse-tran- scription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospec- tive, multicenter study. Surgery. 2014;3:417–23.
15. Yaguchi Y, Sugasawa H, Tsujimoto H, Takata H, Nakabayashi K, Ichikura T, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Am Surg Oncol. 2011;8:2289.
16. Natsugoe S, Arigami T, Uenosono Y, Yanagita S. Novel surgical approach based on the sentinel node concept in patients with early gastric cancer. Ann Gastroenterol Surg. 2017;1:180–5.
17. Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. The pre- dictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Ann Surg Oncol. 2012;19:1529–34.
18. Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 2009;35:409–14.
19. Morgagni P, Saragoni L, Scarpi E, Zattini PS, Zaccaroni A, Morgagni D, et al. Lymph node micrometastases in early gastric cancer and their impact on prognosis. World J Surg. 2003;27:558–61.
20. Ito S, Ohashi Y, Sasako M. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial. BMC Cancer. 2018;18:449.
21. Kim YJ, Chung WC, Youn GJ, Jun KH, Chin HM. The predic- tive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer. Rev Esp Enferm Dig. 2019;111:537–42.
22. Xu X, Zheng G, Zhang T, Zhao Y, Zheng Z. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol. 2019;84:635–46.
23. Saka M, Katai H, Fukagawa T, Nijjar R, Sano T. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer. 2008;11:214–8.
24. Uchida M, Kondo Y, Suzuki S, Hosohata K. Evaluation of acute kidney injury associated with anticancer drugs used in gastric cancer in the Japanese adverse drug event report database. Ann Pharmacother. 2019;53:1200–6.